Bone Marrow Transplant Clinical Trial
Official title:
Technology-assisted, In-home Remote Patient Monitoring, Telemedicine, and Home-based Health Care for Treatment of Bone Marrow Transplant Patients.
This study is designed to assess the potential for successfully using technology-assisted in-home oncology care, including remote patient monitoring (RPM), telemedicine, and home-based health care services to support improved care management and appropriate referral to treatment for bone marrow transplant (BMT) patients.
Study participants will complete an onboarding session into the Oncology at Home care program prior to discharge from the hospital. During the onboarding process, participants will be introduced to the RC care team, confirm understanding of their customized care plan treatment and goals as established by their BMT care provider, will receive an oral thermometer for use during the study, and will complete patient education. Working with the study team and RC RN, participants will receive, affix, activate, and test a wearable RPM device (the BioIntellisense BioSticker) prior to discharge from the BMT unit. As the BioSticker needs to be replaced every 30 days, patients will also receive three additional BioStickers new in packaging for use during months 2 and 3 as well as to have a back-up device in case of malfunction. Patients will return the BioSticker to BioIntelliSense with the postage paid return envelope provided at discharge. The BioSticker will report skin temperature data once per hour, along with additional vital sign information (heart rate, respiratory rate, estimated body temperature, frequency of severe cough episodes, activity level, body position, sleep duration, degree of incline while sleeping, step count, step symmetry, step strength, and on/off body times). Participants will be expected to wear the BioSticker 24 hours per day, 7 days per week, and to also track and log their temperature manually with the oral thermometer according to usual care practice at a minimum of twice per day. RPM data will be monitored 24 hours per day, 7 days per week by Reimagine Care, Inc. Advanced Practice Providers (APPs) from the Reimagine Care, Inc. Virtual Care Center (VCC). During daytime business hours, APPs will monitor in real time from the VCC. After business hours and on weekends, APPs will be on call and will be automatically notified through a mobile device in case of elevated temperature or other alert of interest. APPs on call will keep the notification device with them at all times. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT02451462 -
Pilot Trial of Zoledronic Acid to Prevent Bone Loss in Hematopoietic Cell Transplant Recipients
|
N/A | |
Completed |
NCT03654599 -
Effects of Digital Stories Intervention on Psychosocial Well-being
|
N/A | |
Active, not recruiting |
NCT04395222 -
Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation
|
Phase 2 | |
Not yet recruiting |
NCT05603156 -
A Study of Olverembatinib Combined With Inotuzumab Ozogamicin in the Treatment ph+ ALL With MRD Persistent Positive
|
N/A | |
Completed |
NCT03530969 -
Geriatric Communication Skills Training Program for Oncology Clinicians
|
N/A | |
Recruiting |
NCT04115241 -
Activity Levels in Bone Marrow Transplant Patients
|
||
Completed |
NCT00143780 -
Pneumonia Vaccine in Bone Marrow Transplant Recipients: Usefulness of Donor Vaccination
|
Phase 4 | |
Completed |
NCT03028961 -
Stanford Letter or Traditional Advance Directive in Advance Care Planning in Patients Undergoing Bone Marrow Transplant
|
N/A | |
Completed |
NCT02575079 -
Parafilm to Prevent CLABSI in Pediatric Patients Undergoing HCT
|
N/A | |
Active, not recruiting |
NCT02665065 -
Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia
|
Phase 3 | |
Completed |
NCT01735565 -
Neutrophil Extracellular Trap Formation in Patients Undergoing Bone Marrow Transplant
|
N/A | |
Completed |
NCT04041219 -
Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients
|
Phase 4 | |
Not yet recruiting |
NCT06361173 -
Spanish BMT4me Usability & Acceptability
|
||
Completed |
NCT03030248 -
Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients
|
Phase 2 | |
Completed |
NCT00695123 -
Screening for Subjects to Participate in Studies of Blood Disorders
|
||
Terminated |
NCT02057289 -
A Pharmacokinetic Study of Pediatric Micafungin Prophylaxis
|
Phase 1 | |
Completed |
NCT04275830 -
The Effects of Heart Rate Variability Biofeedback Training on Hematopoietic Cell Transplantation Patients
|
N/A | |
Completed |
NCT03902210 -
BMT Online Wellness Study
|
N/A | |
Completed |
NCT03245788 -
Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study
|
N/A | |
Completed |
NCT03758911 -
Perspectives on Bone Marrow Donors Who Donate for Their Parent
|